Literature DB >> 1702815

Lactoferrin-lipopolysaccharide interactions. Effect on lactoferrin binding to monocyte/macrophage-differentiated HL-60 cells.

K Miyazawa1, C Mantel, L Lu, D C Morrison, H E Broxmeyer.   

Abstract

Lactoferrin (LF) has been implicated in a number of functions including the negative regulation of myelopoiesis in vitro and in vivo, an effect mediated by suppression of cytokine release from monocytes/macrophages. This suppression is abrogated by bacterial LPS. In the present study, HL-60 cells were induced to differentiate to monocytes/macrophages by 12-O-tetradecanoyl phorbol-13-acetate, and LF-binding assays were performed. After differentiation, HL-60 cells showed a twofold increase of LF-binding sites with no difference in the specificity or affinity of LF between pre- and post-differentiated cells. CD11a, CD11b, and CD11c Ag, which have been associated with specific binding sites for LPS on monocytes/macrophages, were also increased three- to fourfold after differentiation. With the use of this system, the effect of LPS on LF binding was studied. At 37 degrees C, LPS enhanced LF binding on HL-60 cells, especially after differentiation. Conversely, at 4 degrees C, LPS inhibited LF binding. There was little effect of temperature on LF binding in the absence of LPS. In the presence of polymyxin B sulfate, the enhanced LF binding by LPS was abrogated. Also, pretreatment with mAbCD11 and/or mAb5D3, which are associated with or directed against candidate LPS receptors, reduced LF binding. Cross-linking studies using an iodinated, photoactivatable LPS derivative ([125I]ASD-LPS) demonstrated directly the specific binding of LPS to LF. These data indicate a dichotomous nature of LF binding on monocyte/macrophage-differentiated HL-60 cells--one being mediated by specific LF receptors whereas the other is apparently mainly via LPS receptors after formation of an LF-LPS complex. These interactions, for which a model is proposed, help to explain the mechanism behind LPS abrogation of the myelopoietic suppressive effects of LF, and a situation that probably occurs during bacterial infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1702815

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Structure and biological actions of lactoferrin.

Authors:  J H Nuijens; P H van Berkel; F L Schanbacher
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

2.  Identification and characterization of lipopolysaccharide-binding proteins on human peripheral blood cell populations.

Authors:  J L Halling; D R Hamill; M G Lei; D C Morrison
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice.

Authors:  M L Kruzel; Y Harari; C Y Chen; G A Castro
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

4.  Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN.

Authors:  William C Adams; Emily Bond; Menzo J E Havenga; Lennart Holterman; Jaap Goudsmit; Gunilla B Karlsson Hedestam; Richard A Koup; Karin Loré
Journal:  J Gen Virol       Date:  2009-03-12       Impact factor: 3.891

5.  The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets.

Authors:  W J Lee; J L Farmer; M Hilty; Y B Kim
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

Review 6.  Role of oxidants in microbial pathophysiology.

Authors:  R A Miller; B E Britigan
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

7.  Lactoferrin is a lipid A-binding protein.

Authors:  B J Appelmelk; Y Q An; M Geerts; B G Thijs; H A de Boer; D M MacLaren; J de Graaff; J H Nuijens
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  Human lactoferrin induces phenotypic and functional changes in murine splenic B cells.

Authors:  M Zimecki; J Mazurier; G Spik; J A Kapp
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

9.  Influence of lactoferrin on the entry process of Escherichia coli HB101 (pRI203) in HeLa cells.

Authors:  C Longhi; M P Conte; L Seganti; M Polidoro; A Alfsen; P Valenti
Journal:  Med Microbiol Immunol       Date:  1993-03       Impact factor: 3.402

10.  Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo.

Authors:  M Machnicki; M Zimecki; T Zagulski
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.